Squar Milner Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,033
Closed -$167K 533
2020
Q1
$167K Sell
2,033
-2,173
-52% -$194K 0.1% 190
2019
Q4
$398K Buy
4,206
+1,741
+71% +$156K 0.2% 112
2019
Q3
$214K Buy
2,465
+469
+23% +$42.1K 0.11% 202
2019
Q2
$182K Buy
1,996
+168
+9% +$14.2K 0.12% 176
2019
Q1
$157K Buy
1,828
+316
+21% +$25.4K 0.12% 199
2018
Q4
$116K Buy
1,512
+183
+14% +$14.2K 0.11% 205
2018
Q3
$103K Sell
1,329
-41
-3% -$3.03K 0.09% 238
2018
Q2
$93K Buy
+1,370
New +$94.5K 0.08% 258

Other funds holding NVS

Squar Milner Financial Services's NVS Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Novartis (NVS) in Q2 2020, closing a stake of 2,033 shares — an estimated $167K sold.

Squar Milner Financial Services first reported a position in NVS in Q2 2018 and held it in 8 quarters. The position peaked at $398K in Q4 2019. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • Squar Milner Financial Services reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 2,033 Novartis shares in Q2 2020, an estimated $167K.
  • Squar Milner Financial Services first reported a position in Novartis in Q2 2018 and held it in 8 quarters.
  • Squar Milner Financial Services's Novartis position peaked at $398K in Q4 2019.
  • 1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.